Table 1.
Subject characteristics.
| Subject | Age (yr) | Duration of hearing loss (yr)a | Duration of implant use (yr) | Etiology | Implant type | Strategy | Experiment participated |
|---|---|---|---|---|---|---|---|
| S01 | 61 | 0.3 | 2 | Unknown | Nucleus 24 | ACE | 1,4 |
| S03 | 61 | 5 | 11 | Genetic | Nucleus 22 | SPEAK | 1,4 |
| S04 | 62 | 1 | 3 | Unknown | Nucleus 24 | ACE | 1,2,4 |
| S12 | 49 | 0 | 2 | Connexin 26 | MED-EL Combi40+ | CIS | 1,2,4 |
| S34 | 55 | 1.5 | Noise exposure | HiRes90K | HiResolution | 1,2,3,4 | |
| S38 | 51 | 9 | 4 | Noise exposure | Nucleus 24 | ACE | 1,4 |
| S40 | 72 | 5 | 6 | Genetic | HiRes90K | HiResolution | 1,4 |
| S41 | 52 | 7 | 5 | Hereditary | HiRes90K | HiResolution | 1,4 |
| S48 | 67 | 10 | 0.5 | Unknown | HiRes90K | HiResolution | 1,2,3,4 |
| S49 | 64 | 4 | 0.75 | Hereditary | HiRes90K | Fidelity120 | 1,4 |
| S51 | 56 | 7 | 6 | Hereditary | Clarion CII | HiResolution | 1,4 |
| S52 | 77 | 0 | 0.5 | Noise exposure | HiRes90K | Fidelity120 | 1,2,3 |
| S53 | 63 | 3 | 7 | Unknown | Clarion CII | Fidelity120 | 1,4 |
| S54 | 25 | 0.5 | 2.5 | Unknown | HiRes90K | HiResolution | 1,4 |
| S55 | 65 | 40 | 1 | Genetic | HiRes90K | Fidelity120 | 1,4 |
| S58 | 64 | 57 | 7 | Noise exposure | Clarion CII | Fidelity120 | 1,4 |
| S59 | 47 | 12 | 2.5 | Noise exposure | HiRes90K | Fidelity120 | 1,4 |
| S61 | 78 | 10 | 1 | Genetic | HiRes90K | Fidelity120 | 1,4 |
| S62 | 32 | 3 | 1 | Unknown | HiRes90K | Fidelity120 | 1,4 |
| S65 | 56 | 2 | 7 | Unknown | Clarion CII | HiResolution | 1,4 |
| S66 | 66 | 3 | 2 | Unknown | HiRes90K | Fidelity120 | 1,4 |
| S69 | 60 | 30 | 2 | Unknown | HiRes90K | Fidelity120 | 1,2,4 |
| S70 | 59 | 0 | 1 | Genetic | Freedom | ACE | 1,4 |
| S71 | 70 | 15 | 1.5 | Genetic | HiRes90K | Fidelity120 | 1,2,3,4 |
a
The duration of their hearing loss before implantation